Multi-drug resistant TB should be treated as a public health emergency

Experts gathered at a conference in London last week called for urgent action to tackle the global problem of multi-drug resistant tuberculosis.

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

LONDON Experts gathered in London last week to call for urgent action to tackle the global problem of multi-drug resistant tuberculosis. Resistance to the commonly used anti-TB drugs is increasing rapidly in many countries of the world, particularly the former Soviet Union.

Mario Raviglione, co-ordinator of TB Strategy and Operations at the World Health Organisation said: "The situation in countries such as Estonia should be treated as a public health emergency on a par with an Ebola outbreak. In general about 2–3% of TB is multi-drug resistant but this rises to 14% of new cases in Estonia."

The meeting, 'TB drug resistance: from molecules to macro-economics', held at the Royal Society of Medicine, gathered together for the first time specialists in many different fields in order to uncover the extent of drug-resistant TB and discuss strategies to deal with it.

Tuberculosis kills two million people each year and the number ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Jacqui Wise

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio